Ernexa Therapeutics Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Ernexa Therapeutics Inc. has filed 1,510 SEC EDGAR filings since 14 Feb 1994

SEC filing history

Showing 476-500 of 1,000 matching filings.

Per page
25
Current page
20
10-K/A File 001-11460

10-K/A filing

Filing date
27 Apr 2020
Reporting date
31 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Apr 2020
Reporting date
21 Apr 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Apr 2020
Reporting date
21 Apr 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-11460

8-K filing

Filing date
21 Apr 2020
Reporting date
18 Apr 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-11460

8-K filing

Filing date
03 Apr 2020
Reporting date
31 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

4/A filing

Filing date
31 Mar 2020
Reporting date
27 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
30 Mar 2020
Reporting date
27 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-11460

8-K filing

Filing date
30 Mar 2020
Reporting date
27 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
25 Mar 2020
Reporting date
25 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
25 Mar 2020
Reporting date
25 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-11460

10-K filing

Filing date
19 Mar 2020
Reporting date
31 Dec 2019
Next action
Verify source filing
SC 13G File 005-42217

SC 13G

Filing date
18 Mar 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-11460

8-K filing

Filing date
17 Mar 2020
Reporting date
12 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Mar 2020
Reporting date
13 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SEC STAFF LETTER

SEC STAFF LETTER filing

Filing date
06 Mar 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Mar 2020
Reporting date
28 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
26 Feb 2020
Reporting date
25 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
26 Feb 2020
Reporting date
25 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
18 Feb 2020
Reporting date
14 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-42217

NTN BUZZTIME

Filing date
11 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SEC STAFF LETTER

SEC STAFF LETTER filing

Filing date
06 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 Feb 2020
Reporting date
31 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
31 Jan 2020
Reporting date
19 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
31 Jan 2020
Reporting date
19 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-11460

8-K filing

Filing date
15 Jan 2020
Reporting date
13 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .